Thus, the MEK and ERK inhibitors induced the effects of LEE011 on NET cells, suggesting that the inhibition of the MAPK signaling could at least partially confer the sensitivity of tumor cells to LEE011. The gene discussed is MAP2K7; the disease is neoplasm.